SLC17A9
Voltage-gated purine nucleotide uniporter SLC17A9
Also known as: C20orf59, FLJ23412, S17A9_HUMAN, VNUT
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BYT1
- Gene
- SLC17A9
- Ensembl
- ENSG00000101194
- Chromosome
- 20
- Canonical length
- 436 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of a family of transmembrane proteins that are involved in the transport of small molecules. The encoded protein participates in the vesicular uptake, storage, and secretion of adenoside triphosphate (ATP) and other nucleotides. A mutation in this gene was found in individuals with autosomal dominant disseminated superficial actinic porokeratosis-8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
Canonical amino-acid sequenceUniProt
436 residues, UniProt reviewed canonical sequence.
>Q9BYT1|SLC17A9
1 MQPPPDEARR DMAGDTQWSR PECQAWTGTL LLGTCLLYCA RSSMPICTVS MSQDFGWNKK
61 EAGIVLSSFF WGYCLTQVVG GHLGDRIGGE KVILLSASAW GSITAVTPLL AHLSSAHLAF
121 MTFSRILMGL LQGVYFPALT SLLSQKVRES ERAFTYSIVG AGSQFGTLLT GAVGSLLLEW
181 YGWQSIFYFS GGLTLLWVWY VYRYLLSEKD LILALGVLAQ SRPVSRHNRV PWRRLFRKPA
241 VWAAVVSQLS AACSFFILLS WLPTFFEETF PDAKGWIFNV VPWLVAIPAS LFSGFLSDHL
301 INQGYRAITV RKLMQGMGLG LSSVFALCLG HTSSFCESVV FASASIGLQT FNHSGISVNI
361 QDLAPSCAGF LFGVANTAGA LAGVVGVCLG GYLMETTGSW TCLFNLVAII SNLGLCTFLV
421 FGQAQRVDLS STHEDLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC17A9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- liver: 39 nTPM
- bone marrow: 11 nTPM
- spleen: 10 nTPM
- stomach: 9 nTPM
- appendix: 5.4 nTPM
- duodenum: 5.1 nTPM
Single-cell type
- hepatocytes: 62 nCPM
- plasma cells: 50 nCPM
- hofbauer cells: 21 nCPM
- hematopoietic stem cells: 21 nCPM
- goblet cells: 18 nCPM
- foveolar cells: 17 nCPM
Immune cell
- NK-cell: 4.9 nTPM
- myeloid DC: 2.6 nTPM
- memory B-cell: 2.2 nTPM
- intermediate monocyte: 1.7 nTPM
- naive B-cell: 1.7 nTPM
- classical monocyte: 0.9 nTPM
Brain region
- white matter: 4.2 nTPM
- medulla oblongata: 2.9 nTPM
- thalamus: 2.7 nTPM
- pons: 2.6 nTPM
- cerebral cortex: 2.2 nTPM
- spinal cord: 2.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC17A9.
Disease | AllUniProt
Conditions SLC17A9 is implicated in, by any mechanism.
- Porokeratosis 8, disseminated superficial actinic type (POROK8) MIM:616063
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 114 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Porokeratosis 8, disseminated superficial actinic type
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.39
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.29
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ADP transport
- ATP export
- ATP transport
- lysosomal protein catabolic process
- guanine nucleotide transmembrane transport
- purine nucleotide import into lysosome
Molecular functions
- ADP transmembrane transporter activity
- ATP transmembrane transporter activity
- guanine nucleotide transmembrane transporter activity
- purine nucleotide uniporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC17A9 as an antibody target. Whether an autoantibody or antibody against SLC17A9 could matter depends on whether native SLC17A9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC17A9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC17A9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...